top of page

The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy

GlobalTort

Even the Economist is Following Genetic Therapies

Kirk Hartley
Feb 11, 2014
1 min read

Change is happening. Even the ever stodgy Economist is paying attention to and writing optimistically about genetic therapies.

Recent Posts

Somatic Signature Mutations - Another Major Leap in Genomics, and Mass Tort Disease Litigation

Somatic Signature Mutations - Another Major Leap in Genomics, and Mass Tort Disease Litigation

A Decade Later - An Update on "A Long Swim" and Research Against ALS

A Decade Later - An Update on "A Long Swim" and Research Against ALS

Due Process in a Trial About 22 Ovarian Cancers - J&J's Cert Petition for Ingham Talc Verdict

As it said it would do, J&J filed a cert petition seeking review of the Ingham verdict against it and others. The verdict involved 22...

Comments

bottom of page